Catalent to Buy Bristol-Myers Manufacturing Plant in Italy
June 19 2019 - 9:38AM
Dow Jones News
By Colin Kellaher
Contract drug maker Catalent Inc. (CTLT) has agreed to buy
Bristol-Myers Squibb Co.'s (BMY) oral solid, biologics and sterile
product manufacturing and packaging plant in Anagni, Italy, for an
undisclosed amount, the companies said Wednesday.
Catalent will continue to make Bristol-Myers' current product
portfolio at the site, along with products for other customers, the
companies said, adding that they expect to complete the transaction
by the end of the year.
The manufacturing plant, with about 63,300 feet of floor space,
sits on an 84-acre site roughly 60 miles southeast of Rome.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
June 19, 2019 09:23 ET (13:23 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024
